Evidence map›Paper›PMID 39562537›Full record

ArticleCell death discovery2024

Chromatin landscape dynamics during reprogramming towards human naïve and primed pluripotency reveals the divergent function of PRDM1 isoforms.

Jianfeng Zhou, Mingyue Guo, Guang Yang, Xinyu Cui, Jindian Hu, Tan Lin, Hong Wang, Shaorong Gao, Cizhong Jiang, Liping Wang and 1 more

Abstract read
In one paragraph

Article in Cell death discovery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jianfeng Zhou *Shanghai Key Laboratory of Maternal and Fetal Medicine, Clinical and Translational Research Center of Shanghai First Maternity and Infant Hospital, School of Life Sciences and Technology, Tongji University, 200092, Shanghai, China.
Mingyue Guo *Frontier Science Center for Stem Cell Research, Tongji University, 200092, Shanghai, China.ORCID http://orcid.org/0000-0002-3582-446X
Guang YangFrontier Science Center for Stem Cell Research, Tongji University, 200092, Shanghai, China.
Xinyu CuiFrontier Science Center for Stem Cell Research, Tongji University, 200092, Shanghai, China.
Jindian HuShanghai Key Laboratory of Maternal and Fetal Medicine, Clinical and Translational Research Center of Shanghai First Maternity and Infant Hospital, School of Life Sciences and Technology, Tongji University, 200092, Shanghai, China.
Tan LinShanghai Key Laboratory of Maternal and Fetal Medicine, Clinical and Translational Research Center of Shanghai First Maternity and Infant Hospital, School of Life Sciences and Technology, Tongji University, 200092, Shanghai, China.
Hong WangShanghai Key Laboratory of Maternal and Fetal Medicine, Clinical and Translational Research Center of Shanghai First Maternity and Infant Hospital, School of Life Sciences and Technology, Tongji University, 200092, Shanghai, China.
Shaorong GaoShanghai Key Laboratory of Maternal and Fetal Medicine, Clinical and Translational Research Center of Shanghai First Maternity and Infant Hospital, School of Life Sciences and Technology, Tongji University, 200092, Shanghai, China. gaoshaorong@tongji.edu.cn.ORCID http://orcid.org/0000-0003-1041-3928
Cizhong JiangFrontier Science Center for Stem Cell Research, Tongji University, 200092, Shanghai, China. czjiang@tongji.edu.cn.ORCID http://orcid.org/0000-0001-5406-2360
Liping WangFrontier Science Center for Stem Cell Research, Tongji University, 200092, Shanghai, China. wlp@tongji.edu.cn.ORCID http://orcid.org/0000-0002-3265-3861
Yixuan WangShanghai Key Laboratory of Maternal and Fetal Medicine, Clinical and Translational Research Center of Shanghai First Maternity and Infant Hospital, School of Life Sciences and Technology, Tongji University, 200092, Shanghai, China. wangyixuan@tongji.edu.cn.ORCID http://orcid.org/0000-0002-2961-6760

Funding

Ministry of Science and Technology of the People's Republic of China (Chinese Ministry of Science and Technology) 2021YFA1100302Ministry of Science and Technology of the People's Republic of China (Chinese Ministry of Science and Technology) 2021YFA11020000National Natural Science Foundation of China (National Science Foundation of China) 32270850National Natural Science Foundation of China (National Science Foundation of China) 32270858
6 · The paper itself

Abstract

Induced pluripotent stem cells (iPSCs) technology holds great potential in both scientific research and clinical applications. It enables the generation of naïve and primed iPSCs from various cell types through different strategies. Despite extensive characterizations of transcriptional and epigenetic factors, the intricacies of chromatin landscape dynamics during naïve and primed reprogramming, particularly in humans, remain poorly understood. In this study, we employed ATAC-seq and RNA-seq analyses to delineate and compare the chromatin landscape of naïve and primed pluripotency through the human secondary reprogramming system. Our investigations revealed several key transcriptional and epigenetic factors pivotal for reprogramming-associated chromatin remodeling. Notably, we found two isoforms of PRDM1, PRDM1α, and PRDM1β, bind to distinct genomic loci and play different roles in the naïve reprogramming process. We proposed an auto-regulatory model explaining the distinct functions of PRDM1α and PRDM1β. Overall, our findings highlight the complexity and diversity of transcription factors in shaping chromatin landscape dynamics and directing the fates of pluripotent cells.

Identifiers

PMID39562537
PMCPMC11576854

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.